<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. __ )*
DAVEL HOLDINGS, INC.
(Name of Issuer)
COMMON STOCK
(Title of Class of Securities)
238341 10 1
(CUSIP Number)
JUSTIN S. MACCARONE
PRESIDENT
UBS CAPITAL II LLC
299 PARK AVENUE
NEW YORK, NEW YORK 10171
(212) 821-6390
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
COPIES TO:
NANCY E. FUCHS, ESQ.
KAYE, SCHOLER, FIERMAN, HAYS & HANDLER, LLP
425 PARK AVENUE
NEW YORK, NEW YORK 10022
(212) 836-8000
DECEMBER 23, 1998
(Date of Event which Requires
Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g),
check the following box [ ].
Note: Schedules filed in paper format shall include a signed original and five
copies of this schedule, including all exhibits. See Section 13d-7(b) for other
parties to whom copies are to be sent.
Page 1 of 46
<PAGE> 2
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 2 of 46
<PAGE> 3
SCHEDULE 13D
CUSIP NO. 238341 10 1
PAGE 3 OF 46 PAGES
- --------------------------------------------------------------------------------
NAMES OF REPORTING PERSONS
1 S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
UBS Capital II LLC 13-3699851
- --------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
2 (SEE INSTRUCTIONS) (a) / /
(b) / /
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
SOURCE OF FUNDS (SEE INSTRUCTIONS)
4
OO
- --------------------------------------------------------------------------------
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
5 REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) / /
- --------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
6
Delaware
- --------------------------------------------------------------------------------
SOLE VOTING POWER
NUMBER OF 7
UBS Capital II LLC owns 892,977 shares of Common
SHARES Stock.
------------------------------------------------------------
BENEFICIALLY SHARED VOTING POWER
8
OWNED BY -0-
------------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
9
REPORTING UBS Capital II LLC owns 892,977 shares of Common
Stock.
PERSON ------------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 10
-0-
- --------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON
11
UBS Capital II LLC owns 892,977 shares of Common
Stock and beneficially owns options to purchase
16,450 shares of Common Stock.
- --------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)
12 EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) / /
- --------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
UBS Capital II LLC owns 9.3% of Common Stock of
13 Issuer as of December 22, 1998 and beneficially owns
options to purchase 16,450 shares of Common Stock
representing an aggregate 9.5% of the Common Stock
of the Issuer as of December 22, 1998.
- --------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
14
OO
- --------------------------------------------------------------------------------
Page 3 of 46
<PAGE> 4
SCHEDULE 13D
CUSIP NO. 238341 10 1 PAGE 4 OF 46 PAGES
- --------------------------------------------------------------------------------
NAMES OF REPORTING PERSONS
1 S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
UBS Capital Holdings LLC 13-3952898
- --------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
2 (SEE INSTRUCTIONS) (a) / /
(b) / /
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
SOURCE OF FUNDS (SEE INSTRUCTIONS)
4
OO
- --------------------------------------------------------------------------------
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
5 REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) / /
- --------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
6
Delaware
- --------------------------------------------------------------------------------
NUMBER OF SOLE VOTING POWER
7
SHARES -0-
------------------------------------------------------------
BENEFICIALLY SHARED VOTING POWER
8
OWNED BY -0-
------------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
9
REPORTING -0-
------------------------------------------------------------
PERSON SHARED DISPOSITIVE POWER
10
WITH -0-
- --------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON
11 UBS Capital II LLC owns 892,977 shares of Common
Stock and beneficially owns options to purchase
16,450 shares of Common Stock; UBS Capital Holdings
LLC, by virtue of the fact that it owns 100% of UBS
Capital II LLC, beneficially owns all such shares.
- --------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)
12 EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) / /
- --------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
UBS Capital II LLC owns 9.3% of Common Stock of
Issuer as of December 22, 1998 and beneficially owns
13 options to purchase 16,450 shares of Common Stock
representing an aggregate 9.5% of the Common Stock
of the Issuer as of December 22, 1998; UBS Capital
Holdings LLC beneficially owns all such stock owned
by UBS Capital II LLC.
- --------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
14
OO
- --------------------------------------------------------------------------------
Page 4 of 46
<PAGE> 5
SCHEDULE 13D
CUSIP NO. 238341 10 1 PAGE 5 OF 46 PAGES
- --------------------------------------------------------------------------------
NAMES OF REPORTING PERSONS
1 S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
UBS AG
- --------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
2 (SEE INSTRUCTIONS) (a) / /
(b) / /
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
SOURCE OF FUNDS (SEE INSTRUCTIONS)
4
OO
- --------------------------------------------------------------------------------
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
5 REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) / /
- --------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
6
Switzerland
- --------------------------------------------------------------------------------
SOLE VOTING POWER
NUMBER OF 7 UBS AG may hold shares of Common Stock for its
customers, of which it may have voting power; such
SHARES information is not currently available.
------------------------------------------------------------
BENEFICIALLY SHARED VOTING POWER
8
OWNED BY -0-
------------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
REPORTING 9 UBS AG may hold shares of Common Stock for its
customers, of which it may have dispositive power;
PERSON such information is not currently
available.
WITH --------------------------------------------------------
SHARED DISPOSITIVE POWER
10
-0-
- --------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON
UBS Capital II LLC owns 892,977 shares of Common
Stock and beneficially owns options to purchase
16,450 shares of Common Stock; UBS Capital Holdings
11 LLC, by virtue of the fact that it owns 100% of UBS
Capital II LLC, beneficially owns all such shares.
UBS AG, by virtue of the fact that it owns 100% of
UBS Capital Holdings LLC, beneficially owns all such
shares, and in addition UBS AG may hold shares of
Common Stock for its customers; such information
is not currently available.
- --------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)
12 EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) / /
- --------------------------------------------------------------------------------
Page 5 of 46
<PAGE> 6
- --------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
UBS Capital II LLC owns 9.3% of Common Stock of
Issuer as of December 22, 1998 and beneficially owns
options to purchase 16,450 shares of Common Stock
representing an aggregate 9.5% of the Common Stock
13 of the Issuer as of December 22, 1998; UBS Capital
Holdings LLC beneficially owns all such stock owned
by UBS Capital II LLC; UBS AG beneficially owns all
such stock owned by UBS Capital Holdings LLC. In
addition USB AG may hold shares of Common Stock for
its customers; such information is not currently
available.
- --------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
14
CO
- --------------------------------------------------------------------------------
Page 6 of 46
<PAGE> 7
ITEM 1. SECURITY AND ISSUER
This Statement relates to shares of Common Stock ("Common
Stock") of Davel Holdings, Inc., a Delaware corporation (the "Company").
The address of the Company's principal executive office is:
1429 Massaro Boulevard, Tampa, Florida 33619.
ITEM 2. IDENTITY AND BACKGROUND
(a) This Statement constitutes the filing on Schedule 13D by
UBS Capital II LLC, a Delaware limited liability company (formerly UBS
Partners, Inc.) ("UBS") with respect to shares of Common Stock received
pursuant to the Amended and Restated Corporate Governance, Liquidity and Voting
Agreement (the "Voting Agreement"), dated as of December 22, 1998, by and among
UBS, Davel Communications Group, Inc. ("Davel"), the Company and Peoples
Telephone Company, Inc. ("Peoples"). Pursuant to such Voting Agreement and in
connection with an Agreement and Plan of Merger and Reorganization (the "Merger
Agreement"), dated as of July 5, 1998, between UBS, Davel and the Company, the
parties to the Voting Agreement agreed that not later than immediately prior to
the effective time of the merger contemplated by the Merger Agreement (the
"Merger"), UBS would convert all of its 150,000 shares of convertible preferred
stock of Peoples (the "Preferred Stock") into shares of common stock of Peoples
(the "Peoples Stock"). In the Merger, such shares would be converted into
671,428 shares of Common Stock. In addition, UBS would be entitled to receive
additional shares of Common Stock in respect of accrued and unpaid dividends on
the Preferred Stock and the agreed-upon future fair value of the Preferred
Stock should they have remained outstanding after the effective time of the
Merger. UBS was also granted registration rights with respect to the shares of
Common Stock to be received. A copy of the Voting Agreement is attached hereto
as Exhibit 2. On December 23, 1998, the Merger was consummated; immediately
prior to the effective time of the Merger, UBS converted its Preferred Stock
into Peoples Stock which, pursuant to the Merger, was converted into 671,428
shares of Common Stock; in addition, pursuant to the Voting Agreement, UBS
received 221,549 additional shares of Common Stock.
This Statement also relates to a 1993 Non-Employee
Director Stock Option Plan of Peoples (the "Option Plan") (a copy of which is
incorporated by reference to pages A-1 through A-4 of the 1993 Proxy Statement
of Peoples Telephone Company Inc.). Pursuant thereto, each non-employee
director of Peoples receives an option to purchase 10,000 shares of Common
Stock annually (the "Options"). Directors of Peoples who were appointed by UBS
received an option to purchase an aggregate of 70,000 shares of Peoples Stock.
Annually, each such director, upon receipt of such Options, has executed an
agreement to transfer to UBS the economic interest in the Options granted to
him. Each such director further agreed to hold the options for the benefit of
UBS and to exercise the rights under the Options only for the benefit of and at
the request of UBS. (A copy of such agreements are Exhibits 3 through 9
hereto).
Page 7 of 46
<PAGE> 8
Pursuant to the Merger Agreement, the Options were converted into options to
purchase 16,450 shares of Common Stock.
A list of the members, directors and executive officers of UBS
appears on Exhibit 1.
UBS is a wholly-owned subsidiary of Holdings, a Delaware
limited liability company ("Holdings"). Holdings is a wholly-owned subsidiary of
UBS AG, a Swiss banking corporation ("UBS AG"). UBS AG is principally engaged in
the general banking business and Holdings is a holding company. A list of the
members, directors and executive officers of Holdings and UBS AG appears on
Exhibit 1.
(b) The address of the principal business office of UBS,
Holdings and UBS AG are as follows:
<TABLE>
<CAPTION>
Reporting Person Address
---------------- -------
<S> <C>
UBS Capital II LLC 299 Park Avenue
New York, New York 10171
UBS Capital Holdings LLC 299 Park Avenue
New York, New York 10171
UBS AG Bahnhofstrasse 45
8021 Zurich
</TABLE>
The address of each of the directors and executive officers of
each of UBS, Holdings and UBS AG are set forth on Exhibit 1.
(c) The present principal occupation or employment of each of
the members, directors and executive officers of each of UBS, Holdings and UBS
AG are set forth on Exhibit 1.
(d) During the past five years, neither UBS, Holdings nor UBS
AG nor, to the knowledge of UBS, Holdings or UBS AG, any of the members,
executive officers or directors of UBS, Holdings or UBS AG, has been convicted
in a criminal proceeding (excluding traffic violations and similar
misdemeanors).
(e) During the past five years, neither UBS, Holdings nor UBS
AG nor, to the knowledge of UBS, Holdings or UBS AG, any of the members,
executive officers or directors of UBS, Holdings or UBS AG, has been a party to
a civil proceeding of a judicial or administrative body of competent
jurisdiction as a result of which such person was or is subject to a judgment,
Page 8 of 46
<PAGE> 9
decree or final order enjoining future violations of, or prohibiting or
mandating activities subject to, federal and state securities laws or finding
any violation with respect to such laws.
(f) Each of UBS and Holdings is a Delaware limited liability
company. To the knowledge of UBS, Holdings and UBS AG, each member, executive
officer and director of UBS and Holdings is a citizen of the United States. UBS
AG is a corporation formed under the laws of Switzerland. To the knowledge of
UBS, Holdings and UBS AG, none of the executive officers and directors of UBS
AG, except Gary Brinson and David Solo, each a member of the group executive
board of UBS AG, is a citizen of the United States.
ITEM 3. SOURCE AND AMOUNT OF FUNDS
Pursuant to the Voting Agreement, immediately prior to the
effective date of the Merger, UBS converted its Preferred Stock into shares of
Peoples Stock which, pursuant to the Merger, were converted into the outstanding
shares of Common Stock. UBS received an additional 221,549 shares of Common
Stock in respect of accrued and unpaid dividends on the Preferred Stock and the
agreed-upon future fair value of the Preferred Stock pursuant to the Voting
Agreement.
ITEM 4. PURPOSE OF TRANSACTION
Pursuant to the Merger, shares of Preferred Stock owned by UBS
were converted into 671,428 shares of Common Stock and the Options were
converted into options to purchase 16,450 shares of Common Stock. UBS received
an additional 221,549 shares of Common Stock in respect of accrued and unpaid
dividends on the Preferred Stock and the agreed-upon future fair value of the
Preferred Stock pursuant to the Voting Agreement.
(a) UBS has no current plans to acquire additional securities
of the Company but possesses registration rights. See the Voting Agreement.
(b) Not applicable.
(c) Not applicable.
(d) UBS has the ability to elect one director of the Company's
Board of Directors until the first anniversary of the effective date of the
Merger; provided, that if at any time prior to such first anniversary UBS ceases
to own less than 95% of the number of shares of Common Stock received by UBS in
the Merger, the UBS director will immediately thereupon resign.
Page 9 of 46
<PAGE> 10
(e) Not applicable.
(f) Not applicable.
(g) Not applicable.
(h) Not applicable.
(i) Not applicable.
(j) Not applicable.
ITEM 5. INTEREST IN SECURITIES OF ISSUER
(a) UBS is the beneficial owner of 892,977 shares of
Common Stock and is also the beneficial owner of options to purchase 16,450
shares of Common Stock, or an aggregate of approximately 9.5% of the issued and
outstanding shares of Common Stock as of December 22, 1998. By virtue of the
fact that Holdings owns 100% of UBS, Holdings is the beneficial owner of all
such stock. By virtue of the fact that UBS AG owns 100% of Holdings, UBS AG is
the beneficial owner of all such stock. In addition, UBS AG may hold shares of
Common Stock for its customers; such information is not currently available.
(b) UBS has the sole power to vote 892,977 shares of Common
Stock. UBS AG may hold shares of Common Stock for its customers; such
information is not currently available.
(c) None.
(d) Not Applicable.
(e) Not Applicable.
Page 10 of 46
<PAGE> 11
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO
SECURITIES OF THE ISSUER
To the knowledge of UBS, Holdings and UBS AG, on the date
hereof, except as set forth herein or in the Exhibits filed herewith or
incorporated by reference, other than the letters executed by each of Justin S.
Maccarone, Charles J. Delaney and UBS on December 14, 1998 in substantially the
form of Exhibit A to the Voting Agreement (attached hereto as Exhibit 2),
neither UBS, Holdings nor UBS AG nor any of the members, directors or executive
officers of UBS, Holdings nor UBS AG has any contracts, arrangements,
understandings or relationships (legal or otherwise) with any person with
respect to any securities of the Company, including, but not limited to,
transfer or voting of any securities of the Company, finder's fee, joint
ventures, loan or option arrangements, puts or calls, guarantees or profits,
division of profits or loss or the giving or withholding of proxies.
ITEM 7. MATERIALS TO BE FILED AS EXHIBITS
Exhibit 1 Information relating to the members of the Board of
Managers, Directors, and Executive Officers of UBS
Capital II LLC, UBS Capital Holdings LLC and UBS AG.
Exhibit 2 Amended and Restated Corporate Governance, Liquidity
and Voting Agreement dated December 22, 1998 by and
among UBS Capital II LLC, Davel Communications Group,
Inc., Davel Holdings, Inc. and Peoples Telephone
Company, Inc.
Exhibit 3 Agreement dated August 25, 1995, by and among UBS
Partners Inc. and Charles J. Delaney (incorporated by
reference to Exhibit 5 filed with Amendment No. 1 to
Schedule 13D relating to common stock of Peoples
Telephone Company, Inc. filed by UBS Capital II LLC,
UBS Capital Holdings LLC and UBS AG on July 17,
1998).
Exhibit 4 Agreement dated August 27, 1996, by and among UBS
Partners Inc. and Charles J. Delaney (incorporated by
reference to Exhibit 6 filed with Amendment No. 1 to
Schedule 13D relating to common stock of Peoples
Telephone Company, Inc. filed by UBS Capital II LLC,
UBS Capital Holdings LLC and UBS AG on July 17,
1998).
Exhibit 5 Agreement dated August 27, 1996, by and among UBS
Partners Inc. and Justin Maccarone (incorporated by
reference to Exhibit 7 filed with Amendment No. 1 to
Schedule 13D relating to common stock of Peoples
Telephone Company, Inc. filed by UBS Capital II LLC,
UBS Capital Holdings LLC and UBS AG on July 17,
1998).
Page 11 of 46
<PAGE> 12
Exhibit 6 Agreement dated July 14, 1997, by and among UBS
Partners LLC and Charles J. Delaney (incorporated by
reference to Exhibit 8 filed with Amendment No. 1 to
Schedule 13D relating to common stock of Peoples
Telephone Company, Inc. filed by UBS Capital II LLC,
UBS Capital Holdings LLC and UBS AG on July 17,
1998).
Exhibit 7 Agreement dated July 14, 1997, by and among UBS
Partners LLC and Justin Maccarone (incorporated by
reference to Exhibit 9 filed with Amendment No. 1 to
Schedule 13D relating to common stock of Peoples
Telephone Company, Inc. filed by UBS Capital II LLC,
UBS Capital Holdings LLC and UBS AG on July 17,
1998).
Exhibit 8 Agreement dated June 16, 1998, by and among UBS
Capital II LLC and Charles J. Delaney (incorporated
by reference to Exhibit 10 filed with Amendment No. 1
to Schedule 13D relating to common stock of Peoples
Telephone Company, Inc. filed by UBS Capital II LLC,
UBS Capital Holdings LLC and UBS AG on July 17,
1998).
Exhibit 9 Agreement dated June 16, 1998, by and among UBS
Capital II LLC and Justin Maccarone (incorporated by
reference to Exhibit 11 filed with Amendment No. 1 to
Schedule 13D relating to common stock of Peoples
Telephone Company, Inc. filed by UBS Capital II LLC,
UBS Capital Holdings LLC and UBS AG on July 17,
1998).
Exhibit 10 Joint Filing Agreement dated January 4, 1999, by and
among UBS Capital II LLC, UBS Capital Holdings LLC
and UBS AG.
Page 12 of 46
<PAGE> 13
Signature
After reasonable inquiry and to the best of our knowledge and
belief, we certify that the information set forth in this Statement is true,
complete and correct.
UBS CAPITAL II LLC
By: /s/ Michael Greene
------------------------------
Name: Michael Greene
Title: Partner
By: /s/ Marc Unger
------------------------------
Name: Marc Unger
Title: Chief Financial Officer
Page 13 of 46
<PAGE> 14
Signature
After reasonable inquiry and to the best of our knowledge and
belief, we certify that the information set forth in this Statement is true,
complete and correct.
UBS CAPITAL HOLDINGS LLC
By: /s/ Michael Greene
------------------------------
Name: Michael Greene
Title: President
By: /s/ Marc Unger
------------------------------
Name: Marc Unger
Title: Chief Financial Officer
Page 14 of 46
<PAGE> 15
Signature
After reasonable inquiry and to the best of our knowledge and
belief, we certify that the information set forth in this Statement is true,
complete and correct.
UBS AG
By: /s/ Lewis Eber
----------------------------
Name: Lewis Eber
Title: Executive Director
By: /s/ Janet Zimmer
----------------------------
Name: Janet Zimmer
Title: Executive Director
Page 15 of 46
<PAGE> 16
EXHIBIT INDEX
<TABLE>
<CAPTION>
Page No.
--------
<S> <C> <C>
Exhibit 1 Information relating to the members of the Board 17
of Managers, Directors, and Executive Officers of UBS
Capital II LLC, UBS Capital Holdings LLC and UBS AG
Exhibit 2 Amended and Restated Corporate Governance, 22
Liquidity and Voting Agreement dated December
22, 1998 by and among UBS Capital II LLC, Davel
Communications Group, Inc., Davel Holdings, Inc.
and Peoples Telephone Company, Inc.
Exhibit 10 Joint Filing Agreement dated January 4, 1999, by 45
and among UBS Capital II LLC, UBS Capital
Holdings LLC and UBS AG
</TABLE>
Page 16 of 46
<PAGE> 1
EXHIBIT 1
UBS CAPITAL II LLC
The names and titles of the members of the board of managers
and executive officers of UBS Capital II LLC and their business addresses and
principal occupations are set forth below. The business addresses of the each of
the following are at UBS Capital II LLC, 299 Park Avenue, New York, New York
10171.
<TABLE>
<S> <C>
Justin S. Maccarone President
George Duarte Partner
Michael Greene Partner and Member of Board of Managers
Charles Delaney Partner
Robert C. Dinerstein VP, Secretary and Member of Board of
Managers
James Breckenridge Principal
Marc Unger Principal, Chief Financial Officer and
Member of Board of Managers
Hyunja Laskin Principal
Charles W. Moore Principal
Sandra Costin Assistant Secretary
Patricia Long Assistant Secretary
</TABLE>
Page 17 of 46
<PAGE> 2
UBS CAPITAL HOLDINGS, LLC
The names and titles of the members of the board of managers
and executive officers of UBS Capital II LLC and their business addresses and
principal occupations are set forth below. The business addresses of the each of
the following are at UBS Capital Holdings LLC, 299 Park Avenue, New York, New
York 10171.
<TABLE>
<S> <C>
Michael Greene President and Member of Board of Managers
Robert C. Dinerstein Managing Director, Secretary and Member of
Board of Managers
Marc Unger Chief Financial Officer, Treasurer and
Member of Board of Managers
Sandra Costin Assistant Secretary
Patricia Long Assistant Secretary
</TABLE>
Page 18 of 46
<PAGE> 3
UBS AG
The names and titles of the members of the Group Executive
Board, directors and executive officers of UBS AG and their business addresses
and principal occupations are set forth below.
DIRECTORS
<TABLE>
<CAPTION>
Name of Director Nationality Address
- ---------------- ----------- -------
<S> <C> <C>
Alberto Togni Swiss UBS AG
Aeschenplatz 6
4002 Basle
Alex Krauer Swiss Novaris AG
Schwarzwaldallee 215
P.O. Box
4002 Basle
Markus Kundig Swiss P.O. Box 4463
6304 Zug
Peter Bockli Swiss Bockli Thomann & Parmer
St. Jakobs-Strasse 41
P.O. Box 2342
4002 Basle
Rolf Arthur Meyer Swiss Ciba Spezialitatenchemise AG
P.O. Box
4002 Basle
Hans Peter Ming Swiss Sika Finanz AG
Zugerstrasse 50
6341 Baar
Andreas Peter Reinhart Swiss Gebruder Volkart Holding AG
P.O. Box 343
8401 Winterthur
Georges P. Schorderet Swiss SAir Group
8058 Zurich-Airport
</TABLE>
Page 19 of 46
<PAGE> 4
<TABLE>
<CAPTION>
Name of Director Nationality Address
- ---------------- ----------- -------
<S> <C> <C>
Manfred Zobl Swiss Swiss Life/Rentenanstalz
P.O. Box 8022
Zurich
</TABLE>
That the names, nationalities and addresses of other responsible
persons of the Company are as follows:
<TABLE>
<CAPTION>
Position in the Company/Name Nationality Address
- ---------------------------- ----------- -------
<S> <C> <C>
Interim Chairman of the Board:
Alex Krauer Swiss Novartis AG
Schwarzwaldallee 215
P.O. Box 4002 Basle
Vice Chairmen:
Alberto Togni Swiss UBS AG
Aeschenplatz 6
4002 Basle
Markus Kundig Swiss P.O. Box 4463
6304 Zug
Chief Executive Officer:
Marcel Ospel Swiss UBS AG
Aeschenplatz 6
4002 Basle
Members of the Group Executive Board:
</TABLE>
Page 20 of 46
<PAGE> 5
<TABLE>
<CAPTION>
Position in the Company/Name Nationality Address
- ---------------------------- ----------- -------
<S> <C> <C>
Johannes De Gier Dutch Warburg Dillon Reed
1, Finsbury Avenue
London EC2M 2PP
Stephan Haeringer Swiss UBS AG
Bahnhofstrasse 45
8021 Zurich
Gary Brinson American Brinson
209 South La Salle Street
Chicago, IL 60604-1295
Rodolfo Bogni Italian UBS AG
Aeschenplatz 6
4002 Basle
David Solo American UBS AG
Bahnhofstrasse 45
8021 Zurich
Pierre de Weck Swiss UBS AG
Bahnhofstrasse 45
8021 Zurich
Peter Wuffli Swiss UBS AG
Aeschenplatz 6
4002 Basle
Corporate Secretary:
Gertrud Erismann Swiss UBS AG
Bahnhofstrasse 45
8021 Zurich
Treasurer:
Peter Wuffli Swiss UBS AG
Aeschenplatz 6
4002 Basle
</TABLE>
Page 21 of 46
<PAGE> 1
EXHIBIT 2
AMENDED AND RESTATED
CORPORATE GOVERNANCE, LIQUIDITY AND VOTING AGREEMENT
This AMENDED AND RESTATED CORPORATE GOVERNANCE, LIQUIDITY AND VOTING
AGREEMENT (the "Agreement"), by and among UBS Capital II LLC ("UBS"), Davel
Communications Group, Inc. ("Davel"), Davel Holdings, Inc. ("Holdings"), and
Peoples Telephone Company, Inc. (the "Company"), is entered into as of December
22, 1998. This Agreement amends and restates in its entirety that certain
Corporate Governance, Liquidity and Voting Agreement (the "Original Agreement"),
dated as of July 5, 1998, by and among the parties hereto.
WHEREAS, concurrently with the execution and delivery of the Original
Agreement, Davel, Holdings and the Company entered into an Agreement and Plan of
Merger and Reorganization (the "Merger Agreement"), dated as of July 5, 1998,
pursuant to which a newly formed subsidiary of Davel or Holdings would be merged
with and into the Company with the Company surviving as a wholly owned
subsidiary of Davel or Holdings;
WHEREAS, Davel, Holdings and the Company have entered into an amended
and restated Merger Agreement (the "Amended Merger Agreement") to provide for
the merger of an indirect, newly formed subsidiary of Holdings with and into the
Company with the Company surviving as an indirect, wholly owned subsidiary of
Holdings (the "Peoples/Davel Merger");
WHEREAS, the consummation of the Peoples/Davel Merger and the other
transactions contemplated by the Amended Merger Agreement (the "Transaction") is
subject to certain conditions, including the approval of the Amended Merger
Agreement by (i) two-thirds of the holders of the outstanding shares of common
stock, par value $.01 per share, of the Company ("Peoples Common Stock") and the
Series C Cumulative Convertible Preferred Stock (the "Series C Preferred"),
voting as a single class, with each share of Series C Preferred entitled to one
vote for each share of Peoples Common Stock issuable upon the conversion thereof
and (ii) by the holders of a majority of the outstanding shares of the Series C
Preferred voting as a separate class;
WHEREAS, 160,000 shares of Series C Preferred have been authorized for
issuance, 150,000 shares of Series C Preferred have been issued and are
outstanding, and UBS is the holder of all 150,000 outstanding shares of Series C
Preferred (the "Preferred Shares");
WHEREAS, the Preferred Shares are convertible into an aggregate of
2,857,143 shares of Peoples Common Stock (the "Common Shares");
WHEREAS, under the terms of the Merger Agreement, upon the conversion
of all of the Preferred Shares into the Common Shares prior to the Effective
Time (as defined below), as contemplated by this Agreement, UBS will be entitled
to receive in the Peoples/Davel Merger, in
Page 22 of 46
<PAGE> 2
exchange for all of the Common Shares, 671,428 shares of the common stock of
Holdings (plus cash in lieu of any fractional share); and
WHEREAS, as a condition to the willingness of the Company, Davel and
Holdings to consummate the transactions contemplated by the Amended Merger
Agreement, UBS has agreed as set forth in this Agreement.
NOW, THEREFORE, in consideration of the representations, warranties,
covenants and agreements contained in this Agreement, the parties hereby agree
as follows:
ARTICLE I
COVENANTS OF UBS
Section 1.1 Agreement to Convert Preferred Shares. UBS covenants and
agrees with the Company, Davel and Holdings that, not later than immediately
prior to the effective time of the Peoples/Davel Merger (the "Effective Time"),
UBS will convert all of the Preferred Shares into the Common Shares issuable
upon conversion of the Preferred Shares and will continue to hold the Common
Shares through the Effective Time. In addition, UBS covenants and agrees with
the Company, Davel and Holdings that it will, except as provided in Section 1.4,
continue to hold the Preferred Shares through the record date of the Peoples
Stockholders Meeting (as hereinafter defined) so that UBS is the holder of
record of all of the Series C Preferred entitled to vote at the Peoples
Stockholders Meeting.
Section 1.2 Agreement to Vote. At any meeting of the stockholders of
the Company held prior to the Termination Date (as hereinafter defined), however
called ("Peoples Stockholders Meeting"), and at every reconvened meeting
following any adjournment or postponement thereof prior to the Termination Date,
or in connection with any written consent of the stockholders of the Company
executed prior to the Termination Date, UBS shall vote all of the Preferred
Shares in favor of the approval of the Merger Agreement, the Peoples/Davel
Merger and any actions required in furtherance thereof which requires
stockholder approval. Prior to the Termination Date and subject to Section 1.4,
UBS shall not enter into any agreement or understanding with any person,
directly or indirectly, to vote, grant any proxy or give instructions with
respect to the voting of the Preferred Shares or the Common Shares issued upon
conversion thereof in any manner inconsistent with the preceding sentence.
Section 1.3 Proxies. (a) UBS hereby revokes any and all previous
proxies granted with respect to matters set forth in Section 1.2 for the
Preferred Shares and the Common Shares.
(b) Prior to the Termination Date, UBS shall not grant any proxies or
powers of attorney with respect to matters set forth in Section 1.2, deposit any
of the Preferred Shares or Common Shares
Page 23 of 46
<PAGE> 3
into a voting trust or enter into a voting agreement, other than this Agreement,
with respect to any of the Preferred Shares or Common Shares, in each case with
respect to such matters.
Section 1.4 Transfer of Shares by UBS. Prior to the Termination Date,
UBS shall not (a) pledge or place any encumbrance on any Preferred Shares or
Common Shares, other than pursuant to this Agreement, or (b) transfer, sell,
exchange or otherwise dispose of any Preferred Shares or Common Shares, in each
case, unless the pledgee, encumbrance holder, transferee, purchaser or acquiror
of such shares enters into a voting agreement with the Company containing
substantially the same terms as are set forth in Sections 1.1, 1.2, 1.3 and 1.4
of this Agreement.
ARTICLE II
REPRESENTATIONS, WARRANTIES AND
ADDITIONAL COVENANTS OF UBS
UBS represents, warrants and covenants to the Company, Davel and
Holdings that:
Section 2.1 Ownership. As of the date of this Agreement, UBS is (and as
of the Original Agreement, UBS was) the beneficial owner of 150,000 Preferred
Shares, free and clear of all liens, charges and encumbrances. UBS will have the
sole right to vote the Preferred Shares and, upon the conversion of the
Preferred Shares, UBS will be the beneficial and record owner of, and have the
sole right to vote, the Common Shares and, subject to this Agreement, there will
be no restrictions on rights of disposition or other liens pertaining to the
Common Shares. UBS has not agreed to subject any Preferred Shares or Common
Shares to any voting trust or other agreement, arrangement or restriction with
respect to the voting of the Preferred Shares or the Common Shares.
Section 2.2 Authority and Non-Contravention. UBS has the right, power
and authority to enter into this Agreement and, subject to the issuance to UBS
of the Common Shares, to consummate the transactions contemplated by this
Agreement. The execution and delivery of this Agreement by UBS and the
consummation of the transactions contemplated by this Agreement have been duly
authorized by all necessary action on the part of UBS. This Agreement has been
duly executed and delivered by UBS and constitutes a valid and binding
obligation of UBS, enforceable against UBS in accordance with its terms, subject
to general principles of equity and as may be limited by bankruptcy, insolvency,
moratorium, or similar laws affecting creditors' rights generally. Neither the
execution and delivery of this Agreement by UBS nor the consummation by UBS of
the transactions contemplated hereby will (i) materially violate, or require any
consent, approval or notice under, any provision of any judgment, order, decree,
statute, law, rule or regulation applicable to UBS, the Preferred Shares or,
upon issuance thereof to UBS, the Common Shares or (ii) violate or conflict with
the certificate of incorporation or bylaws of UBS or constitute a material
violation of or default under any contract, commitment, agreement,
understanding, arrangement or other restriction of any kind to which UBS is a
party or by which UBS or its assets are bound.
Page 24 of 46
<PAGE> 4
Section 2.3 Total Shares. As of the date of this Agreement, UBS does
not own (and as of the date of the Original Agreement, UBS did not own),
beneficially (other than through ownership of the Series C Preferred or through
options granted to representatives of UBS in their capacity as directors of the
Company) or of record, any shares of capital stock of the Company. Other than
the Preferred Shares and options granted to representatives of UBS in their
capacity as directors of the Company, UBS does not have any option to purchase
or right to subscribe for or otherwise acquire any securities of the Company and
has no other interest in or voting rights with respect to any other securities
of the Company.
Section 2.4 Notifications. Prior to the Termination Date, UBS will
notify the Company promptly of the number of any shares of capital stock of the
Company acquired by UBS after the date of the Original Agreement.
Section 2.5 Delivery of Affiliate Letter. In the event that counsel to
the Company reasonably determines that UBS is an affiliate of the Company for
purposes of Rule 145 under the Securities Act of 1933, as amended, or for
purposes of pooling-of-interests accounting treatment, UBS agrees to execute and
deliver to the Company not later than 30 days prior to the Effective Time an
Affiliate Letter substantially in the form attached hereto as Exhibit A.
ARTICLE III
COVENANTS OF THE COMPANY, DAVEL AND HOLDINGS
Each of the Company, Davel and Holdings covenants to UBS on behalf of
itself that:
Section 3.1 Corporate Governance. Davel and Holdings agree that at the
Effective Time and thereafter, Davel and Holdings shall exercise all authority
to cause Charles J. Delaney or Justin S. Maccarone, as determined by UBS
(including any principal or employee of UBS or one of its affiliates who is
appointed by UBS to replace such initial designee, the "UBS Designee") to be
elected as a member of the Board of Directors of Holdings until the first
anniversary of the Effective Time; provided, however, that if UBS shall at any
time during such one-year period be the beneficial owner of less than 95% of the
number of shares of common stock of Holdings received by UBS in the
Peoples/Davel Merger (i.e., 848,328 shares, subject to adjustment for stock
splits, combinations and reclassifications), then the UBS Designee shall
immediately thereupon resign as a member of such Board of Directors.
Section 3.2 Merger Consideration for the Preferred Shares. Davel,
Holdings and the Company agree with UBS that, at the Effective Time, the
2,857,143 Common Shares into which UBS shall have converted the 150,000
Preferred Shares shall be entitled to receive therefor 671,428 shares of common
stock of Holdings, plus cash in lieu of any fractional share. In addition, in
consideration of accrued but unpaid dividends on the Preferred Shares plus the
agreed-upon future fair value of the Preferred Shares should they have remained
outstanding after the Effective Time, Davel and Holdings
Page 25 of 46
<PAGE> 5
shall pay or cause to be paid to UBS upon the consummation of the Peoples/Davel
Merger an additional 189,735 (plus such additional number as will equal in value
(calculated based on the Exchange Ratio set forth in the Merger Agreement
multiplied by the closing price of the common stock of Davel on the trading day
immediately prior to the date of the Original Agreement) any additional
dividends on the Preferred Shares accruing after the date of the Original
Agreement and prior to the Effective Time) shares (plus cash in lieu of any
fractional share) of the common stock of Holdings.
Section 3.3 Registration Rights. UBS, the Company, Davel and Holdings
agree that, as of the Effective Time, all of the rights of UBS and all of the
obligations of the Company and its successors and assigns as set forth in the
Registration Rights Agreement, dated as of July 19, 1995, by and among the
Company, UBS and Appian Capital Partners, L.L.C. (as amended, the "Existing
Registration Agreement") shall terminate and, with respect to such parties, the
Existing Registration Agreement shall be of no further force or effect. In lieu
thereof, in the event that the UBS Designee resigns or is otherwise no longer
serving or, in accordance with Section 3.1, is no longer entitled to serve as a
member of the Board of Directors of Davel or Holdings, the provisions set forth
in Exhibit B hereto shall become effective.
Section 3.4 Contingent Stock Purchase Warrant. Reference is made to the
Contingent Stock Purchase Warrant issued by the Company to UBS (the "Contingent
Warrant") pursuant to the Securities Purchase Agreement, dated as of July 3,
1995, by and among the Company, UBS and Appian Capital Partners, L.L.C. (the
"Purchase Agreement"). UBS, the Company, Davel and Holdings agree that, as of
the Effective Time, all of the rights of UBS and all of the obligations of the
Company and its successors and assigns as set forth in the Contingent Warrant
and the Purchase Agreement shall terminate and be of no further force or effect,
UBS shall deliver the Contingent Warrant to Holdings immediately after the
Effective Time, and the Contingent Warrant shall be canceled.
ARTICLE IV
REPRESENTATIONS, WARRANTIES AND ADDITIONAL COVENANTS OF
THE COMPANY, DAVEL AND HOLDINGS
Each of the Company, Davel and Holdings represents, warrants and
covenants to UBS on behalf of itself that:
Section 4.1 Authority and Non-Contravention. It has the right, power
and authority to enter into this Agreement and to consummate the transactions
contemplated by this Agreement. The execution and delivery of this Agreement by
it and the consummation of the transactions contemplated by this Agreement have
been duly authorized by all necessary action on the part of it. This Agreement
has been duly executed and delivered by it and constitutes a valid and binding
obligation of it, enforceable against it in accordance with its terms, subject
to general principles of
Page 26 of 46
<PAGE> 6
equity and as may be limited by bankruptcy, insolvency, moratorium or similar
laws affecting creditors' rights generally. Neither the execution and delivery
of this Agreement nor the consummation by it of the transactions contemplated
hereby will (i) materially violate, or require any consent, approval or notice
under, any provision of any judgment, order, decree, statute, law, rule or
regulation applicable to it or (ii) violate or conflict with the certificate or
articles of incorporation or by laws of it or constitute a material violation of
or default under any contract, commitment, agreement, understanding, arrangement
or other restriction of any kind to which it is a party or by which it or its
assets are bound.
ARTICLE V
MISCELLANEOUS
Section 5.1 Expenses. All costs and expenses incurred in connection
with this Agreement shall be paid by the party incurring such costs or expenses;
provided, however, that the Company shall pay reasonable fees and expenses of
counsel to UBS incurred in connection with the negotiation and execution of this
Agreement.
Section 5.2 Further Assurances. From time to time, at the request of
the Company, Davel or Holdings in the case of UBS, or at the request of UBS in
the case of the Company, Davel or Holdings, and without further consideration,
each party shall execute and deliver or cause to be executed and delivered such
additional documents and instruments and take all such further action as may be
reasonably necessary or desirable to consummate the transactions contemplated by
this Agreement.
Section 5.3 Specific Performance. Each party hereto agrees that the
other parties hereto would be irreparably damaged if for any reason it fails to
perform any of its obligations under this Agreement, and that the other parties
would not have an adequate remedy at law for money damages in such event.
Accordingly, the aggrieved party shall be entitled to seek specific performance
and injunctive and other equitable relief to enforce the performance of this
Agreement by the other parties hereto. This provision is without prejudice to
any other rights that each party may have against the other parties hereto for
any failure to perform their obligations under this Agreement.
Section 5.4 Amendments, Termination. This Agreement may not be modified
or amended except by an instrument or instruments in writing signed by each
party hereto. The representations, warranties, covenants and agreements set
forth in Article I, Article II, Article III (other than Sections 3.1 and 3.3
thereof) and Article IV shall terminate, except with respect to liability for
prior breaches thereof, upon the earliest to occur of (i) termination of the
Amended Merger Agreement in accordance with its terms, (ii) the Closing Date (as
defined in the Amended Merger Agreement) and (iii) the date, if any, upon which
the Company's Board of Directors withdraws, modifies or changes its
recommendation or approval of the Merger Agreement or the Peoples/Davel Merger
in a manner adverse to Davel and Holdings (the "Termination Date").
Page 27 of 46
<PAGE> 7
Section 5.5 Assignment. Subject to Section 1.4 hereof and the
provisions of Exhibit B, neither this Agreement nor any of the rights, interests
or obligations under this Agreement shall be assigned, in whole or in part, by
operation of law or otherwise by any of the parties without the prior written
consent of the other parties. Subject to the preceding sentence, this Agreement
shall be binding upon, and inure to the benefit of, the parties hereto and their
respective successors and assigns.
Section 5.6 Entire Agreement. This Agreement (including the documents
referred to herein) (a) constitutes the entire agreement, and supersedes all
prior agreements and understandings, both oral and written between the parties
with respect to the subject matter of this Agreement and (b) is not intended to
confer upon any person other than the parties hereto any rights or remedies.
Without limiting the generality of the foregoing, this Agreement supersedes the
Original Agreement in its entirety.
Section 5.7 Notices. All notices and other communications hereunder
shall be in writing and shall be deemed given if delivered personally, sent by
documented overnight delivery service or telecopied with confirmation of
receipt, to the parties at the addresses specified below (or at such other
address or telecopy or telex number for a party as shall be specified by like
notice):
If to the Company, to:
Peoples Telephone Company, Inc.
2300 N.W. 89th Place
Miami, Florida 33172
Attention: General Counsel
Facsimile: (305) 593-6116
with copies to:
Steel Hector & Davis LLP
200 South Biscayne Blvd.
Miami, Florida 33131-2398
Attention: Ira N. Rosner, P.A.
Facsimile: (305) 577-7001
and
Shearman & Sterling
599 Lexington Avenue
New York, New York 10022
Attention: John Madden, Esq.
Facsimile: (212) 848-7179
Page 28 of 46
<PAGE> 8
If to Davel or Holdings, to:
Davel Communications Group, Inc.
1429 Massaro Boulevard
Tampa, Florida 33619
Attention: Theodore C. Rammelkamp, Jr.
Facsimile: (813) 626-9610
with a copy to:
Kirkland & Ellis
200 East Randolph Drive
Chicago, Illinois 60601
Attention: R. Scott Falk
Facsimile: (312) 861-2200
If to UBS, to:
UBS Capital II LLC
299 Park Avenue
New York, New York 10171
Attention: Justin S. Maccarone
Facsimile: (212) 821-6333
with a copy to:
Kaye, Scholer, Fierman, Hays & Handler, LLP
425 Park Avenue
New York, New York 10022
Attention: Nancy Fuchs
Facsimile: (212) 836-7150
Section 5.8 Governing Law. This Agreement shall be governed by, and
construed in accordance with, the laws of the State of New York regardless of
the laws that might otherwise govern under applicable principles of conflicts of
laws thereof.
Section 5.9 Counterparts. This Agreement may be executed in two or more
counterparts, all of which shall be considered one and the same agreement, and,
shall become effective when one or more counterparts have been signed by each of
the parties and delivered to the other parties in original or facsimile form.
Page 29 of 46
<PAGE> 9
Section 5.10 Interpretation. The headings contained in this Agreement
are inserted for convenience of reference only and shall not affect in any way
the meaning or interpretation of this Agreement.
Section 5.11 Severability. Any provision hereof which is invalid or
unenforceable shall be ineffective to the extent of such invalidity or
unenforceability, without affecting in any way the remaining provisions hereof.
Section 5.12 Consent to Jurisdiction. Each party hereto irrevocably
submits to the nonexclusive jurisdiction of (a) the state courts of the State of
New York and (b) the United States federal district courts located in the State
of New York for the purposes of any suit, action or other proceeding arising out
of this Agreement or any transaction contemplated hereby.
Section 5.13 Attorney's Fees. If any action at law or in equity is
necessary to enforce or interpret the terms of this Agreement, the prevailing
party shall be entitled to reasonable attorneys' fees, costs and necessary
disbursements, in addition to any other relief to which such party may be
entitled.
* * * * *
Page 30 of 46
<PAGE> 10
each of the parties as of the date first above written.
UBS CAPITAL II LLC
By: /s/ JUSTIN MACCARONE
---------------------------
Name: Justin Maccarone
Title: President
By: /s/ HYUNJA LASKIN
--------------------------
Name: Hyunja Laskin
Title: Principal
PEOPLES TELEPHONE COMPANY, INC.
By: /s/ BRUCE W. RENARD
---------------------------
Name: Bruce W. Renard
Title: Executive Vice President &
General Counsel
DAVEL HOLDINGS, INC.
By: /s/ THEODORE C. RAMMELKAMP, JR.
-----------------------------------
Name: Theodore C. Rammelkamp, Jr.
Title: Senior Vice President
DAVEL COMMUNICATIONS GROUP, INC.
By: /s/ THEODORE C. RAMMELKAMP, JR.
-----------------------------------
Name: Theodore C. Rammelkamp, Jr.
Title: Senior Vice President
Page 31 of 46
<PAGE> 11
EXHIBIT A
Davel Communications Group, Inc.
1429 Massaro Boulevard
Tampa, Florida 33619
Dear Sirs:
The undersigned, a holder of shares of common stock, par value
$.01 per share ("Peoples Common Stock"), of Peoples Telephone Company, Inc., a
New York corporation ("Peoples"), is entitled to receive in connection with the
merger (the "Merger") of Peoples with and into an indirect, wholly owned
subsidiary of Davel Holdings, Inc., a Delaware corporation ("Davel"), shares of
common stock, par value $0.01 per share (the "Davel Common Stock"), of Davel.
The undersigned has been advised that the undersigned may be deemed an
"affiliate" of Peoples within the meaning of Rule 145 ("Rule 145") promulgated
under the Securities Act of 1933, as amended (the "Securities Act"), by the
Securities and Exchange Commission (the "SEC") and may be deemed an "affiliate"
of Peoples for purposes of qualifying the Merger for pooling of interests
accounting treatment under Opinion 16 of the Accounting Principles Board and
applicable SEC rules and regulations. Nothing contained herein should be
construed as an admission that I am an "affiliate" of Peoples as described in
the immediately preceding sentence.
If, in fact, the undersigned were an affiliate under the
Securities Act, the undersigned's ability to sell, assign or transfer the shares
of Davel Common Stock received by the undersigned in exchange for any shares of
Peoples Common Stock in connection with the Merger may be restricted unless such
transaction is registered under the Securities Act or an exemption from such
registration is available. The undersigned understands that such exemptions are
limited and the undersigned has obtained or will obtain advice of counsel as to
the nature and conditions of such exemptions, including information with respect
to the applicability to the sale of such securities of Rules 144 and 145(d)
promulgated under the Securities Act. The undersigned understands that Davel
will not be required to maintain the effectiveness of any registration statement
under the Securities Act for the purposes of sale, transfer or other disposition
of shares of Davel Common Stock by the undersigned (other than pursuant to the
registration rights provided to the undersigned pursuant to the Amended and
Restated Corporate Governance, Liquidity and Voting Agreement, dated as of
December 22, 1998) or take any action (other than to comply with the reporting
requirements of the Securities Exchange Act of 1934, as amended, so long as it
is subject to such requirements) to make compliance with an exemption from
registration available to the undersigned.
The undersigned hereby represents to and covenants with Davel
that the undersigned will not sell, assign or transfer any of the shares of
Davel Common Stock received by the undersigned in exchange for shares of Peoples
Common Stock in connection with the Merger except (i) pursuant to an effective
registration statement under the Securities Act, (ii) in conformity with the
volume and
A-1 Page 32 of 46
<PAGE> 12
other limitations of Rule 145 or (iii) in a transaction which, in the opinion of
the general counsel of Davel or other counsel reasonably satisfactory to Davel
or as described in a "no-action" or interpretive letter from the staff of the
SEC specifically issued with respect to a transaction to be engaged in by the
undersigned, is not required to be registered under the Securities Act.
The undersigned hereby further represents to and covenants
with Davel that from the date that is 30 days prior to the Closing Date (as
defined in the Amended and Restated Agreement and Plan of Merger, dated as of
July 5, 1998, and amended and restated as of October 22, 1998, by and among
Davel, Davel Holdings, Inc. and Peoples), the undersigned will not sell,
transfer or otherwise dispose of any shares of Peoples Common Stock held by the
undersigned and that the undersigned will not sell, transfer or otherwise
dispose of any shares of Davel Common Stock received by the undersigned in the
Merger until after such time as results covering at least 30 days of post-Merger
combined operations of Peoples and Davel have been published by Davel, in the
form of a quarterly earnings report, an effective registration statement filed
with the SEC, a report to the SEC on Form 10-K, 10-Q or 8-K, or any other public
filing or announcement which includes such combined results of operations,
except after prior written notice to Davel of the undersigned's intention to
make such sale and Davel's determination that such sale would not reasonably be
expected to adversely affect the qualification of the Merger as a
pooling-of-interests.
In the event of a sale or other disposition by the undersigned
of shares of Davel Common Stock pursuant to Rule 145 or other exempt
transaction, the undersigned will supply Davel with evidence of compliance with
such Rule, in the form of a letter in the form of Annex I hereto or the opinion
of counsel or no-action letter referred to above, as the case may be. The
undersigned understands that Davel may instruct its transfer agent to withhold
the transfer of any shares of Davel Common Stock disposed of by the undersigned,
but that (provided such transfer is not prohibited by any other provision of
this letter agreement) upon receipt of such evidence of compliance, Davel shall
cause the transfer agent to effectuate the transfer of the shares of Davel
Common Stock sold as indicated in such letter.
The undersigned acknowledges and agrees that the legend set
forth below will be placed on certificates representing the Davel Common Stock
received by the undersigned in connection with the Merger or held by a
transferee thereof, which legend will be removed by delivery of substitute
certificates upon receipt of an opinion in form and substance reasonably
satisfactory to Davel from counsel reasonably satisfactory to Davel to the
effect that such legend is no longer required for purposes of the Securities
Act.
There will be placed on the certificates for Davel Common
Stock issued to the undersigned, or any substitutions therefor, a legend stating
in substance:
"THE SHARES REPRESENTED BY THIS CERTIFICATE WERE ISSUED
PURSUANT TO A BUSINESS COMBINATION WHICH IS BEING ACCOUNTED FOR AS A POOLING OF
INTERESTS, IN A TRANSACTION TO WHICH RULE 145 PROMULGATED UNDER THE SECURITIES
ACT OF 1933 APPLIES. THE SHARES HAVE NOT BEEN ACQUIRED BY THE HOLDER WITH A VIEW
TO, OR FOR RESALE IN CONNECTION WITH, ANY DISTRIBUTION THEREOF
A-2 Page 33 of 46
<PAGE> 13
WITHIN THE MEANING OF THE SECURITIES ACT OF 1933. THE SHARES MAY NOT BE SOLD,
PLEDGED OR OTHERWISE TRANSFERRED (i) UNTIL SUCH TIME AS DAVEL SHALL HAVE
PUBLISHED FINANCIAL RESULTS COVERING AT LEAST 30 DAYS OF COMBINED OPERATIONS
AFTER THE EFFECTIVE TIME AND (ii) EXCEPT IN ACCORDANCE WITH AN EXEMPTION FROM
THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT OF 1933."
The undersigned acknowledges that (i) the undersigned has
carefully read this letter and understands the requirements hereof and the
limitations imposed upon the distribution, sale, transfer or other disposition
of Davel Common Stock and (ii) the receipt by Davel of this letter is an
inducement to Davel's obligations to consummate the Merger.
Very truly yours,
A-3 Page 34 of 46
<PAGE> 14
ANNEX I TO EXHIBIT A
[Date]
[Name]
On____________, the undersigned sold shares of common stock
(the "Davel Common Stock") of Davel Communications, Inc. (f/k/a Davel Holdings,
Inc.), a Delaware corporation ("Davel"), which were received by the undersigned
in connection with the merger of Peoples Telephone Company, Inc. with and into a
wholly owned subsidiary of Davel.
Based upon the most recent report or statement filed by Davel
with the Securities and Exchange Commission, the shares of Davel Common Stock
sold by the undersigned were within the prescribed limitations set forth in
paragraph (e) of Rule 144 promulgated under the Securities Act of 1933, as
amended (the "Securities Act").
The undersigned hereby represents that the shares of Davel
Common Stock were sold in "brokers' transactions" within the meaning of Section
4(4) of the Securities Act or in transactions directly with a "market maker" as
that term is defined in Section 3(a)(38) of the Securities Exchange Act of 1934,
as amended. The undersigned further represents that the undersigned has not
solicited or arranged for the solicitation of orders to buy the Davel Common
Stock, and that the undersigned has not made any payment in connection with the
offer or sale of the Davel Common Stock to any person other than to the broker
who executed the order in respect of such sale.
Very truly yours,
A-4 Page 35 of 46
<PAGE> 15
EXHIBIT B
(a) All capitalized terms used but not defined in this Exhibit B shall
have the meanings assigned to them in the Agreement to which this Exhibit B is
attached. For purposes of the provisions contained in this Exhibit B:
(i) The term "Common Stock" means the common stock, par value
$.01 per share, of Davel Communications, Inc. (f/k/a Davel Holdings,
Inc.), a Delaware corporation.
(ii) The term "Holder" means, at any given time, UBS, provided
that UBS owns of record shares of Common Stock of the Issuer at such
time, and any affiliate of UBS who then owns of record Registrable
Securities, provided that such affiliate has previously executed and
delivered a written counterpart to this Agreement.
(iii) The term "Issuer" means Davel Communications, Inc.
(f/k/a Davel Holdings, Inc.), a Delaware corporation.
(iv) The term "register," "registered" and "registration"
refer to a registration effected by preparing and filing a registration
statement in compliance with the Securities Act.
(v) The term "Registrable Securities" means shares of Common
Stock of the Issuer held, from time to time, by any Holder.
(vi) The term "Rule 415 Offering" means an offering on a
delayed or continuous basis pursuant to Rule 415 (or any successor rule
to similar effect) promulgated under the Securities Act.
(vii) The term "SEC" means the Securities and Exchange
Commission or any governmental agency that is a successor thereto.
(viii) The term "Securities Act" means the Securities Act of
1933, as amended, and the rules and regulations promulgated thereunder.
(ix) The term "Shelf Registration Statement" means a
registration statement intended to effect a shelf registration in
connection with a Rule 415 Offering.
(b) On a single occasion, the Issuer shall, upon the written request of
Holder, prepare and file with the SEC a registration statement with respect to
all or any portion of (or at the request of UBS a Shelf Registration Statement
with respect to all shares of) the Issuer's Common Stock acquired by UBS in or
in connection with the Peoples/Davel Merger for distribution of such stock in
the manner or manners specified in such request and use its reasonable best
efforts to cause such registration statement to become effective and keep such
registration statement effective until such
B-1 Page 36 of 46
<PAGE> 16
time as such shares have been sold or disposed of thereunder or sold,
transferred or otherwise disposed of to a person that is not a Holder (but in
any event, with respect to a registration statement other than a Shelf
Registration Statement, no later than the third anniversary of the date such
registration statement becomes effective); provided, however, that Holder shall
not be entitled to demand registration of Common Stock pursuant to this
paragraph (b) in an underwritten public offering if, at the time of such
request, such Holder does not beneficially own at least 25% of the number of
shares of Common Stock received by UBS in or in connection with the
Peoples/Davel Merger; and provided further that if, at any time after giving a
written request for registration (other than a shelf registration) and prior to
the effective date of the registration statement filed in connection with such
request, the managing underwriters of such offering determine that the aggregate
amount of shares requested to be registered by the Holders of the Registrable
Securities, together with the amount of shares requested by all persons and
entities ("Other Persons") exercising (with respect to such offering) incidental
registration rights granted to such Other Persons by Davel or Holdings, could
materially and adversely affect such offering, then the Issuer may reduce the
number of Registrable Securities of such Holders to be included in such offering
to the maximum number of shares that the underwriters deem advisable, and the
Issuer will allocate the number of securities to be registered among such
Holders and Other Persons on a pro rata basis in accordance with the number of
shares each Holder and Other Person initially requested to be sold (it being
understood that if, as a result of such reduction and allocation, less than 75%
of the Registrable Securities requested by such Holders to be included in such
offering are so included, then the Holders shall again be entitled to the
benefits of this paragraph (b)). Notwithstanding the foregoing, if the Issuer
shall furnish to Investor a certificate signed by the Chief Executive, Chief
Operating, or Chief Financial Officer of the Issuer stating that, in the good
faith judgment of a majority of the Issuer's directors, it would be materially
detrimental to the Issuer for such registration statement to be filed, the
Issuer shall have the right to defer such filing for a period of not more than
90 days after receipt of UBS' request; provided that the Issuer may not utilize
this right more than once in any 12-month period.
(c) If the Issuer proposes to register any Common Stock to be issued by
it or held by any other person ("Other Securities") in a public offering under
the Securities Act, on a form and in a manner which would permit registration of
Registrable Securities for sale to the public under the Securities Act, it will
give prompt written notice to each Holder of its intention to do so, and upon
the written request of a Holder delivered to the Issuer within fifteen business
days after the giving of any such notice (which request shall specify the
Registrable Securities intended to be disposed of by such Holder and the
intended method of disposition thereof), the Issuer will use its reasonable best
efforts to effect, in connection with the registration of the Other Securities,
the registration under the Securities Act of all Registrable Securities which
the Issuer has been so requested to register by such Holder, to the extent
required to permit the disposition (in accordance with the intended method or
methods thereof as aforesaid) of the Registrable Securities so to be registered,
provided that:
(i) if, at any time after giving such written notice of its
intention to register any Other Securities and prior to the effective
date of the registration statement filed in connection with such
registration, the managing underwriters of such offering or offerings
determine that
B-2 Page 37 of 46
<PAGE> 17
the aggregate amount of shares to be registered by the Holders of the
Registrable Securities, together with all other shares requested by all
other persons or entities to be included in such offering, could
materially and adversely affect such offering, then the Issuer may
reduce the number of Registrable Securities of such Holders or such
other persons or entities to be included in such offering to the
maximum number of shares that the underwriters deem advisable, and the
Issuer will allocate the number of securities to be registered among
such Holders and other persons or entities on a pro rata basis in
accordance with the number of shares each Holder and other person or
entity initially requested to be sold.
(ii) the Issuer shall not be required to effect any
registration of Registrable Securities under this paragraph (c)
incidental to the registration of any of its securities in connection
with (A) mergers, acquisitions or exchange offers on Form S-4 or any
successor form, (B) dividend reinvestment plans or (C) stock option or
other employee benefit plans; and
(iii) Holders, cumulatively, shall have the right to exercise
registration rights pursuant to this paragraph (c) without limit during
the term hereof.
No registration of Registrable Securities effected under this paragraph (c)
shall relieve the Issuer of its obligation to effect a registration of
Registrable Securities pursuant to paragraphs (b) or (c).
(d) Whenever the Issuer is required to effect a registration statement
pursuant to paragraphs (b) or (c), the Issuer shall, as expeditiously as
reasonably possible:
(i) Prepare and file with the SEC such amendments and
supplements to such registration statement and the prospectus used in
connection therewith as may be necessary to comply with the provisions
of the Securities Act with respect to the disposition of all securities
covered thereby.
(ii) Furnish to the Holders such numbers of copies of a
prospectus, including a preliminary prospectus, in conformity with the
requirements of the Securities Act, and such other documents as they
may reasonably request in order to facilitate the disposition of
Registrable Securities covered by such registration statement owned by
them.
(iii) Use its reasonable best efforts to register and qualify
the securities covered by such registration statement under such other
securities or Blue Sky laws of such states or other jurisdictions as
shall be reasonably requested by any Holder, provided that the Issuer
shall not be required to qualify to do business or to file a general
consent to service of process in any such states or jurisdictions where
it is not so subject.
(iv) Notify each Holder of Registrable Securities covered by
such registration statement at any time when a prospectus relating
thereto is required to be delivered under the Securities Act of the
happening of any event as a result of which the prospectus included in
such registration statement, as then in effect, includes an untrue
statement of a material fact
B-3 Page 38 of 46
<PAGE> 18
or omits to state a material fact required to be stated therein or
necessary to make the statements therein not misleading in the light of
the circumstances then existing, and then use its best efforts to
promptly correct such statement or omission. Notwithstanding the
foregoing and anything to the contrary set forth in this paragraph (d),
each Holder acknowledges that the Issuer shall have the right to
suspend the use of the prospectus forming a part of a registration
statement if such offering would interfere with a pending corporate
transaction or for other reasons until such time as an amendment to the
registration statement has been filed by the Issuer and declared
effective by the SEC, or until such time as the Issuer has filed an
appropriate disclosure report with the SEC. Each Holder hereby
covenants that it will (i) keep any such notice strictly confidential,
and (ii) not sell any shares of Common Stock pursuant to such
prospectus during the period commencing at the time at which the Issuer
gives the Holder notice of the suspension of the use of such prospectus
and ending at the time the Issuer gives the Holder notice that it may
thereafter effect sales pursuant to such prospectus. The Issuer shall
only be able to suspend the use of such prospectus for periods
aggregating no more than 90 days in respect of any registration.
(v) Make available for inspection by any Holder of Registrable
Securities included in such registration statement, any underwriter
participating in any offering pursuant to such registration statement,
and any attorney, accountant or other agent retained by any such Holder
or underwriter (collectively, the "Inspectors"), all financial and
other records and other information, pertinent corporate documents and
properties of any of the Issuer and its subsidiaries and affiliates
(collectively, the "Records"), as shall be reasonably necessary to
enable them to exercise their due diligence responsibilities; provided,
however, that the Records that the Issuer determines, in good faith, to
be confidential and which it notifies the Inspectors in writing are
confidential shall not be disclosed to any Inspector unless such
Inspector signs a confidentiality agreement reasonably satisfactory to
the Issuer (which shall permit the disclosure of such Records in such
registration statement or the related prospectus if necessary to avoid
or correct a material misstatement in or material omission from such
registration statement or prospectus) and either (i) the disclosure of
such Records is necessary to avoid or correct a misstatement or
omission in such registration statement or (ii) the release of such
Records is ordered pursuant to a subpoena or other order from a court
of competent jurisdiction; provided, further, that (A) any decision
regarding the disclosure of information pursuant to subclause (i) shall
be made only after consultation with counsel for the applicable
Inspectors and the Issuer and (B) with respect to any release of
Records pursuant to subclause (ii), each Holder of Registrable
Securities agrees that it shall, promptly after learning that
disclosure of such Records is sought in a court having jurisdiction,
give notice to the Issuer so that the Issuer, at the Issuer's expense,
may undertake appropriate action to prevent disclosure of such Records.
(vi) Enter into such customary agreements (including
underwriting agreements in customary form) and take all such other
actions as the Holders of a majority of the Registrable Securities
being sold or the underwriters, if any, reasonably request in order to
expedite or facilitate the disposition of such Registrable Securities
(including obtaining opinions of
B-4 Page 39 of 46
<PAGE> 19
counsel and "cold comfort" letters and updates thereof from the
Issuer's independent certified public accountants).
(e) It shall be a condition precedent to the obligations of the Issuer
to take any action pursuant to this Agreement with respect to the Registrable
Securities of any selling Holder that such Holder shall furnish to the Issuer
such information regarding itself, the Registrable Securities held by it, and
the intended method of disposition of such securities as shall be required to
effect the registration of such Holder's Registrable Securities and as may be
required from time to time to keep such registration current.
(f) All expenses incurred by or on behalf of the Issuer in connection
with registrations, filings or qualifications pursuant to paragraphs (b) or (c),
including, without limitation, all registration, filing and qualification fees,
printers' and accounting fees, and fees and disbursements of counsel for the
Issuer, shall be borne by the Issuer. In no event shall the Issuer be obligated
to bear any underwriting discounts or commissions or brokerage fees or
commissions relating to Registrable Securities or, except as otherwise set forth
herein, the fees and expenses of counsel to the selling Holders.
(g) In the event of registration of any Registrable Securities
hereunder:
(i) To the extent permitted by law, the Issuer will indemnify
and hold harmless each Holder and the affiliates of such Holder, and
their respective directors, officers, general and limited partners,
agents and representatives (and the directors, officers, affiliates and
controlling persons thereof), and each other person, if any, who
controls such Holder within the meaning of the Securities Act, against
any losses, claims, damages, or liabilities ("Losses"), joint or
several, to which they may become subject under the Securities Act or
other federal or state law, insofar as such Losses (or actions in
respect thereof) arise out of or are based upon any of the following
statements, omissions or violations (collectively a "Violation"): (i)
any untrue statement or alleged untrue statement of a material fact
contained in such registration statement, including any preliminary
prospectus (provided that this indemnity shall not apply to the extent
that the Losses are attributable to an untrue statement or alleged
untrue statement of any material fact or omission or alleged omission
to state a material fact in a preliminary prospectus that was corrected
in a final prospectus which was provided to the Holder on a timely
basis but which the Holder or the underwriters failed to deliver to the
purchaser within the time required by applicable securities laws)
contained therein or any amendments or supplements thereto, (ii) the
omission or alleged omission to state therein a material fact required
to be stated therein, or necessary to make the statements therein not
misleading (but only if such omission is not corrected in the final
prospectus), or (iii) any violation or alleged violation by the Issuer
in connection with the registration of Registrable Securities under the
Securities Act, any state securities law or any rule or regulation
promulgated under the Securities Act or any state securities law; and
the Issuer will pay to each such Holder, affiliate or controlling
person, as incurred, any legal or other expenses reasonably incurred by
them in connection with investigating or defending any such
B-5 Page 40 of 46
<PAGE> 20
Loss or action; provided, however, that the indemnity contained in this
subparagraph (g)(i) shall not apply to amounts paid in settlement of
any such loss, claim, damage, liability or action if such settlement is
effected without the consent of the Issuer (which consent shall not be
unreasonably withheld), nor shall the Issuer be liable in any such case
for any such loss, claim, damage, liability or action to the extent
that it arises out of or is based upon a Violation which occurs in
reliance upon and in conformity with written information furnished
expressly for use in connection with such registration by or on behalf
of such Holder or its Affiliates or controlling person. Each
indemnified party shall furnish such information regarding itself or
the claim in question as an indemnifying party may reasonably request
in writing and as shall be reasonably required in connection with the
defense of such claim and litigation resulting therefrom.
(ii) To the extent permitted by law, each selling Holder will
indemnify and hold harmless the Issuer, each of its directors, each of
its officers who has signed the registration statement, each person, if
any, who controls the Issuer within the meaning of the Securities Act,
any underwriter, any other Holder selling securities in such
registration statement and any controlling person of any such
underwriter or other Holder, against any Losses, joint or several, to
which any of the foregoing persons may become subject, under the
Securities Act or other federal or state law, insofar as such losses,
claims, damages or liabilities (or actions in respect thereto) arise
out of or are based upon any Violation, in each case to the extent (and
only to the extent) that such Violation occurs in reliance upon and in
conformity with written information furnished by such Holder expressly
for use in connection with such registration; and each such Holder will
pay, as incurred, any legal or other expenses reasonably incurred by
any person intended to be indemnified pursuant to this subparagraph
(g)(ii) in connection with investigating or defending any such loss,
claim, damage, liability or action; provided, however, that the
indemnity contained in this subparagraph (g)(ii) shall not apply to
amounts paid in settlement of any such Loss or action if such
settlement is effected without the consent of such Holder, which
consent shall not be unreasonably withheld; provided, that, in no event
shall any indemnity under this subparagraph (g)(ii) exceed the gross
proceeds from the offering received by such Holder.
(iii) Promptly after receipt by an indemnified party of notice
of the commencement of any action (including any governmental action),
such indemnified party will, if a claim in respect thereof is to be
made against any indemnifying party under this paragraph (g), deliver
to the indemnifying party a written notice of the commencement thereof
and the indemnifying party shall have the right to participate in, and,
to the extent the indemnifying party so desires, jointly with any other
indemnifying party similarly noticed, to assume the defense thereof
with counsel mutually satisfactory to the parties. The failure to
deliver written notice to the indemnifying party within a reasonable
time after the commencement of any such action, if materially
prejudicial to its ability to defend such action, shall relieve such
indemnifying party of any liability to the indemnified party under this
paragraph (g) to the extent of such prejudice, but the omission so to
deliver written notice to the indemnifying party will not relieve it of
any liability that it may have to any indemnified party otherwise than
under this
B-6 Page 41 of 46
<PAGE> 21
paragraph (g). The indemnified party shall have the right, but not the
obligation, to participate in the defense of any action referred to
above through counsel of its own choosing and shall have the right, but
not the obligation, to assert any and all separate defenses, cross
claims or counterclaims which it may have, and the fees and expenses of
such counsel shall be at the expense of such indemnified party unless
(A) the employment of such counsel has been specifically authorized in
advance by the indemnifying party, (B) there is a conflict of interest
that prevents counsel for the indemnifying party from adequately
representing the interests of the indemnified party or there are
defenses available to the indemnified party that are different from, or
additional to, the defenses that are available to the indemnifying
party, (C) the indemnifying party does not employ counsel that is
reasonably satisfactory to the indemnified party within a reasonable
period of time, or (D) the indemnifying party fails to assume the
defense or does not reasonably contest such action in good faith, in
which case, if the indemnified party notifies the indemnifying party
that it elects to employ separate counsel, the indemnifying party shall
not have the right to assume the defense of such action on behalf of
the indemnified party and the reasonable fees and expenses of such
separate counsel shall be borne by the indemnifying party; provided,
however, that, the indemnifying party shall not, in connection with any
proceeding or related proceedings in the same jurisdiction, be liable
for the reasonable fees and expenses of more than one separate firm (in
addition to, to the extent reasonably necessary to employ local
counsel, one firm acting as local counsel) for all indemnified parties.
(iv) If the indemnification provided for in this paragraph (g)
is unavailable to an indemnified party in respect of any Losses (other
than in accordance with its terms), then each applicable indemnifying
party, in lieu of indemnifying such indemnified party, shall contribute
to the amount paid or payable by such indemnified party as a result of
such Losses, in such proportion as is appropriate to reflect the
relative fault of the indemnifying party, on the one hand, and such
indemnified party, on the other hand, in connection with the actions,
statements or omissions that resulted in such Losses as well as any
other relevant equitable considerations. The relative fault of such
indemnifying party, on the one hand, and indemnified party, on the
other hand, shall be determined by reference to, among other things,
whether any action in question, including any untrue statement of a
material fact or omission or alleged omission to state a material fact,
has been taken by, or relates to information supplied by, such
indemnifying party or indemnified party, and the parties' relative
intent, knowledge, access to information and opportunity to correct or
prevent any such action, statement or omission. The amount paid or
payable by a party as a result of any Losses shall be deemed to include
any legal or other fees or expenses incurred by such party in
connection with any investigation or proceeding. No contribution
required by this paragraph to be made by any Holder shall exceed the
gross proceeds from the offering received by such Holder.
(v) The obligations of the Issuer and the Holders under this
paragraph (g) shall survive the completion of any offering of
Registrable Securities in a registration statement under this
Agreement.
B-7 Page 42 of 46
<PAGE> 22
(vi) Notwithstanding the foregoing, to the extent that the
provisions on indemnification and contribution contained in the
underwriting agreement (if any) entered into in connection with any
underwritten public offering of the Registrable Securities are in
conflict with the foregoing provisions, the provisions in such
underwriting agreement shall control.
(h) With a view to making available to the holders the benefits of Rule
144 and any other rule or regulation of the SEC that may at any time permit a
Holder to sell securities of the Issuer to the public without registration or
pursuant to a registration on Form S-3, the Issuer agrees to:
(i) use its reasonable best efforts to make and keep public
information available, as those terms are understood and defined in
Rule 144;
(ii) use its reasonable best efforts to file with the SEC in a
timely manner all reports and other documents required under the
Securities Act and the Securities Exchange Act of 1934, as amended; and
(iii) furnish to any Holder forthwith upon request (i) a
written statement by the Issuer as to its compliance with the reporting
requirements of Rule 144, or as to whether it qualifies as a registrant
whose securities may be resold pursuant to Form S-3, (ii) a copy of the
most recent annual or quarterly report of the Issuer and such other
reports and documents so filed by the Issuer, and (iii) such other
information (and the Issuer shall take such action) as may be
reasonably requested in availing any Holder of any rule or regulation
of the SEC which permits the selling of any such securities without
registration or pursuant to such form.
(i) The rights to cause the Issuer to register Registrable Securities
pursuant to this Agreement may only be assigned by a Holder to a transferee or
assignee of any Registrable Securities if such transferee or assignee is or
becomes a Holder in connection with such transfer or assignment.
(j) The observance by the Issuer of any provision of this Agreement may
be waived (either generally or in a particular instance and either retroactively
or prospectively) with the written consent of the Holders of a majority of the
Registrable Securities, and any waiver effected in accordance with this
paragraph shall be binding upon each Holder of Registrable Securities.
(k) Each Holder of Registrable Securities, if requested by an
underwriter of any registered public offering of Issuer securities being sold in
a firm commitment underwriting, agrees not to sell or otherwise transfer or
dispose of any Common Stock (or other voting securities of the Issuer) held by
such Holder other than shares of Registrable Securities included in the
registration during the seven days prior to, and during a period of up to 180
days following, the effective date of the registration statement. Such agreement
shall be in writing in a form reasonably satisfactory to the Issuer and such
underwriter. The Issuer may impose stop-transfer instructions with respect to
the securities subject to the foregoing restriction until the end of the
required stand-off period.
B-8 Page 43 of 46
<PAGE> 23
Notwithstanding the foregoing, Holder shall only be bound by the provisions of
this paragraph (k) if all other holders of Common Stock entitled to registration
rights are similarly restricted.
B-9 Page 44 of 46
<PAGE> 1
EXHIBIT 10
JOINT FILING AGREEMENT
The undersigned hereby agree to file jointly the Statement on
Schedule 13D (the "Schedule") relating to the Common Stock of Davel Holdings,
Inc. and any further amendments thereto which may be deemed necessary pursuant
to Regulation 13D or G promulgated under Section 13 of the Securities Exchange
Act of 1934, as amended.
It is understood and agreed that a copy of this Agreement
shall be attached as an exhibit to this Statement, filed upon behalf of each of
the parties hereto.
This Agreement may be executed in multiple counterparts, each
of which shall constitute an original, one and the same instrument.
IN WITNESS WHEREOF, each of the undersigned has executed this
Agreement as of January 4, 1999.
UBS CAPITAL II LLC
By: /s/ Michael Greene
------------------------------
Name: Michael Greene
Title: Partner
By: /s/ Marc Unger
------------------------------
Name: Marc Unger
Title: Chief Financial Officer
UBS CAPITAL HOLDINGS LLC
By: /s/ Michael Greene
------------------------------
Name: Michael Greene
Title: President
By: /s/ Marc Unger
------------------------------
Name: Marc Unger
Title: Chief Financial Officer
Page 45 of 46
<PAGE> 2
UBS AG
By: /s/ Lewis Eber
----------------------------
Name: Lewis Eber
Title: Executive Director
By: /s/ Janet Zimmer
----------------------------
Name: Janet Zimmer
Title: Executive Director
Page 46 of 46
